HOMEPAGE
Fully Diluted Subscribe

Nasdaq · Biotech stocks database

EVO — Evotec SE

EVO (Evotec SE) stock: $1.69, $601.2M market cap, $318.3M cash, $606.5M EV, $610.7M fully diluted market cap. Data from Fully Diluted's biotech stocks database.

What they do

Our ambition is to lead the way by combining comprehensive disease understanding at the molecular level with cutting-edge technologies, transforming this knowledge into precise, life-changing medicines through collaborative partnerships. We aim to reshape the future of healthcare by providing flexible access for our partners in the pharmaceutical and biotechnology industry to our platform across the continuum of discovery, development and manufacturing.

Source: 20-F FY2025 via SEC EDGAR

Share price
$1.69
Market cap
$601.2M
Cash
$318.3M
Enterprise value
$606.5M

Balance sheet

Cash$318.3M
Debt$323.6M
Net cash-$5.3M
Enterprise value$606.5M
Basic shares177.8M shares
Fully diluted shares361.4M shares
Fully diluted market cap$610.7M
Cash per share$1.79

Cash figures as of 2024-12-31. Database snapshot: 2026-11-07.

Share structure

Common
355.6M
Pre-funded warrants
—
Options
0.0M
RSUs
5.8M
Warrants
0.0M
Converts
0.0M
Conv preferred
0.0M
ESPP reserve
—
FDSO
361.4M

Cap table as of 2025-12-31.

Price history

Loading EVO daily closes…

Loading price history…
Get the weekly biotech catalyst rundown.
Cash runways, financings, and trial readouts for all 721 stocks.
Subscribe to Compounding Ego